CMC Corporation (TYO:2185)

Verve Therapeutics Revenue

CMC Corporation had revenue of 5.22B JPY in the quarter ending March 31, 2025, a decrease of -12.41%. This brings the company's revenue in the last twelve months to 18.82B, up 4.16% year-over-year. In the fiscal year ending September 30, 2024, CMC Corporation had annual revenue of 19.52B with 5.81% growth.

• Revenue (ttm): 18.82B
• Revenue Growth: +4.16%
• P/S Ratio: 1.09
• Revenue / Employee: 21.84M
• Employees: 862
• Market Cap: 20.60B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Sep 30, 2024	19.52B	1.07B	5.81%
Sep 30, 2023	18.45B	534.00M	2.98%
Sep 30, 2022	17.92B	586.00M	3.38%
Sep 30, 2021	17.33B	260.00M	1.52%
Sep 30, 2020	17.07B	-2.18B	-11.32%